Literature DB >> 10225917

Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pylori infection after oral vaccination of mice.

T Goto1, A Nishizono, T Fujioka, J Ikewaki, K Mifune, M Nasu.   

Abstract

C57BL/6 mice were orally immunized with five weekly doses of 2 mg, 200 microgram, or 2 microgram of Helicobacter pylori (Sydney strain) whole-cell sonicate combined with cholera toxin. One week after the last vaccination, mice were challenged with 5 x 10(7) CFU of live H. pylori three times at 2-day intervals. At 6 or 18 weeks after the challenge, mice were sacrificed and bacterial cultures and histological studies of the stomach were performed. Vaccination with 2 mg/session or 200 microgram/session inhibited H. pylori colonization by 90 and 100%, respectively. These mice were considered protected. Lower levels of H. pylori-specific immunoglobulin A (IgA) were detected in fecal and saliva samples before challenge. However, a significant increase in IgA secretion in mucosal tissue and a higher labeling index for IgA-positive lumina of pyloric glands were noted in these mice in response to challenge and in a vaccine dose-dependent manner. In protected mice, however, severe gastritis characterized by marked infiltration of inflammation mononuclear cells was noted at 6 weeks after challenge, compared with the gastritis seen in unprotected mice or nonvaccinated, ordinarily infected mice. Marked expression of gamma interferon mRNA was detected in the stomach of all protected mice, and 50% of these mice expressed interleukin 4 (IL-4) or IL-5 mRNA. Our findings suggest that local secretory IgA antibody and severe postimmunization gastritis correlate well with protection of mice against H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225917      PMCID: PMC116000     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA.

Authors:  K Tokunaga; H Taniguchi; K Yoda; M Shimizu; S Sakiyama
Journal:  Nucleic Acids Res       Date:  1986-03-25       Impact factor: 16.971

2.  The use of avidin-biotin interaction in immunoenzymatic techniques.

Authors:  J L Guesdon; T Ternynck; S Avrameas
Journal:  J Histochem Cytochem       Date:  1979-08       Impact factor: 2.479

3.  Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

Authors:  D Y Graham; G M Lew; P D Klein; D G Evans; D J Evans; Z A Saeed; H M Malaty
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

4.  Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II.

Authors:  T Kinashi; N Harada; E Severinson; T Tanabe; P Sideras; M Konishi; C Azuma; A Tominaga; S Bergstedt-Lindqvist; M Takahashi
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

5.  Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine.

Authors:  A Lee; M Chen
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

6.  Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis.

Authors:  J Pappo; W D Thomas; Z Kabok; N S Taylor; J C Murphy; J G Fox
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.

Authors:  P Michetti; I Corthésy-Theulaz; C Davin; R Haas; A C Vaney; M Heitz; J Bille; J P Kraehenbuhl; E Saraga; A L Blum
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Vitamin A is required for regulation of polymeric immunoglobulin receptor (pIgR) expression by interleukin-4 and interferon-gamma in a human intestinal epithelial cell line.

Authors:  J Sarkar; N N Gangopadhyay; Z Moldoveanu; J Mestecky; C B Stephensen
Journal:  J Nutr       Date:  1998-07       Impact factor: 4.798

9.  Cloning and expression of murine immune interferon cDNA.

Authors:  P W Gray; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Schistosomes, liver flukes and Helicobacter pylori.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1994
View more
  37 in total

1.  Comparative analysis of colonization of Helicobacter pylori and glycolipids receptor density in Mongolian gerbils and mice.

Authors:  H Osawa; K Sugano; M Iwamori; M Kawakami; M Tada; M Nakao
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

4.  Inhibition of H. pylori colonization and prevention of gastritis in murine model.

Authors:  Mahdieh Ameri Shah Reza; Seyed Latif Mousavi Gargari; Iraj Rasooli; Mohammadreza Jalali Nadoushan; Walead Ebrahimizadeh
Journal:  World J Microbiol Biotechnol       Date:  2012-04-28       Impact factor: 3.312

5.  Childhood Helicobacter pylori infection in a murine model: maternal transmission and eradication by systemic immunization using bacterial antigen-aluminium hydroxide.

Authors:  T Minoura; S Kato; S Otsu; T Fujioka; K Iinuma; A Nishizono
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Helicobacter cinaedi cellulitis and bacteremia in immunocompetent hosts after orthopedic surgery.

Authors:  Toshio Kitamura; Yoshiaki Kawamura; Kiyofumi Ohkusu; Takayuki Masaki; Hirofumi Iwashita; Tomohiro Sawa; Shigemoto Fujii; Tatsuya Okamoto; Takaaki Akaike
Journal:  J Clin Microbiol       Date:  2006-11-01       Impact factor: 5.948

7.  Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori.

Authors:  Zheng Jiang; Ai-Long Huang; Xiao-Hong Tao; Pi-Long Wang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

8.  Construction of expression systems for flaA and flaB genes of Helicobacter pylori and determination of immunoreactivity and antigenicity of recombinant proteins.

Authors:  Jie Yan; Shao-Hui Liang; Ya-Fei Mao; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

9.  Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice.

Authors:  K Watanabe; K Murakami; R Sato; T Okimoto; K Maeda; M Nasu; A Nishizono; T Fujioka
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.